The Journal of Urology
Volume 179, Issue 4 , Pages 1243-1256, April 2008

A Comprehensive Approach Toward Novel Serum Biomarkers for Benign Prostatic Hyperplasia: The MPSA Consortium

  • Chris Mullins

      Affiliations

    • National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, Maryland
    • Financial interest and/or other relationship with AUA Research Council.
    • ,
  • M. Scott Lucia

      Affiliations

    • Prostate Diagnostic Laboratory and MPSA Pathology Coordinating Center, Department of Pathology, University of Colorado Denver and Health Sciences Center, Aurora, Colorado
    • Financial interest and/or other relationship with GlaxoSmithKline and Veridex.
    • ,
  • Simon W. Hayward

      Affiliations

    • Departments of Urologic Surgery and Cancer Biology, Vanderbilt University Medical Center, Nashville, Tennessee
    • ,
  • Jeannette Y. Lee

      Affiliations

    • Medical Statistics Section, The University of Alabama at Birmingham, Birmingham, Alabama
    • ,
  • Jonathan M. Levitt

      Affiliations

    • Scott Department of Urology, Baylor College of Medicine, Houston, Texas
    • Department of Immunology, Baylor College of Medicine, Houston, Texas
    • Baylor College of Medicine, Houston, Texas
    • ,
  • Victor K. Lin

      Affiliations

    • Department of Urology, The University of Texas, Southwest Medical Center, Dallas, Texas
    • ,
  • Brian C.-S. Liu

      Affiliations

    • Molecular Urology Laboratory, Brigham and Women’s Hospital, Boston, Massachusetts
    • ,
  • Arul M. Chinnaiyan

      Affiliations

    • Harvard Medical School, Brigham and Women’s Hospital, Boston, Massachusetts
    • Broad Institute of the Massachusetts Institute of Technology and Harvard, Cambridge, Massachusetts
    • Financial interest and/or other relationship with Compendia, Gen-Probe and Rubicon.
    • ,
  • Mark A. Rubin

      Affiliations

    • Harvard Medical School, Brigham and Women’s Hospital, Boston, Massachusetts
    • Broad Institute of the Massachusetts Institute of Technology and Harvard, Cambridge, Massachusetts
    • ,
  • Kevin Slawin

      Affiliations

    • Scott Department of Urology, Baylor College of Medicine, Houston, Texas
    • Financial interest and/or other relationship with Beckman Coulter, Inc.
    • ,
  • Robert A. Star

      Affiliations

    • National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, Maryland
    • ,
  • Robert H. Getzenberg

      Affiliations

    • James Buchanan Brady Urological Institute, Johns Hopkins University School of Medicine, Baltimore, Maryland
    • Financial interest and/or other relationship with University of Pittsburgh and Johns Hopkins University.
    • Corresponding Author InformationCorrespondence: James Buchanan Brady Urological Institute, Johns Hopkins Hospital, 600 N. Wolfe St., Marburg 121, Baltimore, Maryland 21287 (telephone: 410-502-3137; FAX: 410-502-9336).
    • ,
  • MPSA Consortium

Received 8 June 2007 published online 18 February 2008.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 30.00 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

 Supported by National Institutes of Health Grants DK63593 (RHG), DK63597 (MSL), DK63587 (SWH), DK63661 (VKL), DK63665 (BC-SL), AG022312 (MAR) and DK63594 (KS).

PII: S0022-5347(07)03088-1

doi:10.1016/j.juro.2007.11.049

The Journal of Urology
Volume 179, Issue 4 , Pages 1243-1256, April 2008

Article Tools

* Image Usage & Resolution